Predictions
Ocugen Inc.
Start price
Target price
Perf. (%)
€13.40
03.05.21
03.05.21
€11.00
03.05.22
03.05.22
-19.25%
04.05.21
04.05.21
Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
Asit Biotech S.a.
Start price
Target price
Perf. (%)
€0.23
16.04.21
16.04.21
€0.40
16.04.22
16.04.22
103.52%
01.05.21
01.05.21
Could be worthwhile Investment >10% per year
Qualtrics International Inc.
Start price
Target price
Perf. (%)
€37.52
16.02.21
16.02.21
€30.00
-21.35%
24.03.21
24.03.21
Low dividend yield expected
Few uniques
Below average Marketposition
Probably not worthwhile Investment
Ocugen Inc.
Start price
Target price
Perf. (%)
€9.02
17.02.21
17.02.21
€12.00
16.05.21
16.05.21
-1.33%
18.02.21
18.02.21
Could be worthwhile Investment >10% per year
Futu Holdings Ltd.
Start price
Target price
Perf. (%)
€36.20
13.11.20
13.11.20
€109.00
13.05.21
13.05.21
234.25%
12.02.21
12.02.21
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
positive Cash Flow expected
Higher risks for its business
Ocugen Inc.
Start price
Target price
Perf. (%)
€11.35
08.02.21
08.02.21
€8.00
08.02.22
08.02.22
-30.04%
11.02.21
11.02.21
Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
Rubius Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.20
14.12.20
14.12.20
€11.00
14.12.21
14.12.21
15.85%
29.01.21
29.01.21
Could be worthwhile Investment >10% per year
Very capable Management
Good culture
Sustainability is little important
Sunworks Inc.
Start price
Target price
Perf. (%)
€24.00
25.01.21
25.01.21
€15.00
25.01.22
25.01.22
-39.58%
28.01.21
28.01.21
Capable Management
Probably not worthwhile Investment
Little innovation
Fastly Inc.
Start price
Target price
Perf. (%)
€74.50
05.12.20
05.12.20
€75.00
8.05%
08.12.20
08.12.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Fastly Inc.
Start price
Target price
Perf. (%)
€68.00
19.11.20
19.11.20
€70.00
5.15%
20.11.20
20.11.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
STS Group AG
Start price
Target price
Perf. (%)
€3.07
21.10.20
21.10.20
€3.00
04.11.21
04.11.21
3.26%
10.11.20
10.11.20
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Leading role in innovation
Revenue growth >5% per year expected